Please use this identifier to cite or link to this item: https://accedacris.ulpgc.es/jspui/handle/10553/149414
Title: Extra-virgin olive oil and additional cardiovascular outcomes in the PREDIMED Trial: An outcome-wide perspective
Authors: de Rojas, Javier Pérez
Toledo, Estefania
Estruch, Ramón
Guasch-Ferré, Marta
Salas-Salvadó, Jordi
Gómez-Gracia, Enrique
Ros, Emilio
Fitó, Montse
Arós, Fernando
Fiol, Miquel
Lapetra, José
Serra Majem, Luis 
Pintó, Xavier
Sorlí, José V.
Babio, Nancy
Castañer, Olga
Alonso-Gómez, Ángel M.
Martínez-González, Miguel Ángel
Jiménez-Moleón, José Juan
UNESCO Clasification: 32 Ciencias médicas
320501 Cardiología
3206 Ciencias de la nutrición
Keywords: Peripheral Artery-Disease
Mediterranean Diet
Heart-Failure
Risk
Consumption, et al
Issue Date: 2025
Journal: The American heart journal 
Abstract: Background: Olive oil, increasingly consumed in the U.S., has been inversely associated with cardiovascular disease (CVD) risk. However, previous studies did not assess a broad spectrum of CVD outcomes, incorporated repeated annual dietary assessments, or distinguished between polyphenol-rich EVOO and common olive oil (COO), which lacks these compounds. Methods: We assessed 7102 high-risk participants from the PREDIMED trial (57.5% women; aged 55-80 years), all free of CVD at baseline. Olive oil consumption was assessed annually, and cumulative average intakes of EVOO and COO were calculated. The primary outcome was a composite of myocardial infarction, stroke, peripheral arterial disease, heart failure, atrial fibrillation, or cardiovascular death, whichever occurred first. Individual outcomes were also evaluated. Time-dependent Cox models were adjusted for major confounders, including trial intervention arm. Results: Over a median follow-up of 4.7 years, 621 participants experienced at least one CVD event. Participants in the highest tertile of cumulative EVOO intake (mean: 49.2 g/d) had a 25% lower risk of the composite outcome (HR: 0.75; 95% CI: 0.60-0.94), with significant reductions in several individual CVD outcomes. In the decile analysis, the highest (mean: 60.9 g/d) versus lowest decile had a 48% lower risk (HR: 0.52; 95% CI: 0.35 to 0.79). COO consumption was not significantly associated with CVD risk when mutually adjusted for EVOO (HRper 10 g/d: 0.93; 95% CI: 0.87-1.00). Conclusions: High consumption of EVOO is associated with a substantial reduction in the risk of an outcome-wide composite of CVD events among high-risk individuals. In contrast, COO, which lacks polyphenols, showed weaker associations, highlighting the importance of differentiating olive oil types in CVD prevention strategies. Trial Registration: This trial was registered in the ISRCTN registry (ISRCTN 35739639): https://www.isrctn.com/ISRCTN35739639.
URI: https://accedacris.ulpgc.es/jspui/handle/10553/149414
ISSN: 0002-8703
DOI: 10.1016/j.ahj.2025.08.021
Source: American Heart Journal[ISSN 0002-8703],v. 291, p. 175-185, (Enero 2026)
Appears in Collections:Artículos
Show full item record

WEB OF SCIENCETM
Citations

1
checked on Feb 1, 2026

Page view(s)

53
checked on Jan 15, 2026

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.